These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

858 related items for PubMed ID: 18675104

  • 1. HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma.
    De Martin E, Senzolo M, Boninsegna S, Guido M, Masier A, Germani G, Tomat S, Brolese A, Neri D, Cillo U, Gambato M, Russo FP, Farinati F, Burra P.
    Transplant Proc; 2008; 40(6):1974-5. PubMed ID: 18675104
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
    Moya A, Berenguer M, Aguilera V, Juan FS, Nicolás D, Pastor M, López-Andujar R, Rayón M, Orbis F, Mora J, De Juan M, Carrasco D, Vila JJ, Prieto M, Berenguer J, Mir J.
    Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
    [Abstract] [Full Text] [Related]

  • 3. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with Hepatitis C.
    Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, Chen P, Dawson S, Durazo F, Han S, Goldstein LI, Saab S, Hiatt J, Busuttil RW.
    Liver Transpl; 2004 Dec; 10(12):1478-86. PubMed ID: 15558585
    [Abstract] [Full Text] [Related]

  • 4. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation.
    Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, Decaens T, Hurtova M, Memeo R, Mallat A, Duvoux C.
    Ann Surg; 2009 Nov; 250(5):738-46. PubMed ID: 19801927
    [Abstract] [Full Text] [Related]

  • 5. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
    Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P.
    Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
    [Abstract] [Full Text] [Related]

  • 6. Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results.
    Mas VR, Fisher RA, Archer KJ, Yanek KC, Williams B, Dumur CI, Maluf DG.
    Transplantation; 2007 Apr 15; 83(7):973-81. PubMed ID: 17460570
    [Abstract] [Full Text] [Related]

  • 7. Recurrence of hepatocellular carcinoma and hepatitis B reinfection in hepatitis B surface antigen-positive patients after liver transplantation.
    Saab S, Yeganeh M, Nguyen K, Durazo F, Han S, Yersiz H, Farmer DG, Goldstein LI, Tong MJ, Busuttil RW.
    Liver Transpl; 2009 Nov 15; 15(11):1525-34. PubMed ID: 19877207
    [Abstract] [Full Text] [Related]

  • 8. Hepatocellular carcinoma in unrelated viral cirrhosis: long-term results after liver transplantation.
    Lauterio A, Di Sandro S, Slim A, Giacomoni A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, De Carlis L.
    Transplant Proc; 2010 May 15; 42(4):1212-5. PubMed ID: 20534264
    [Abstract] [Full Text] [Related]

  • 9. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.
    Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.
    Transplant Proc; 2008 Jun 15; 40(5):1481-4. PubMed ID: 18589133
    [Abstract] [Full Text] [Related]

  • 10. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF, Molina E, Bustamante M, Tomé S, Otero E, Martínez J, Segade FR, Conde R, Varo E.
    Transplant Proc; 2008 Nov 15; 40(9):2975-7. PubMed ID: 19010164
    [Abstract] [Full Text] [Related]

  • 11. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course.
    Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE.
    Liver Transpl; 2009 Dec 15; 15(12):1872-81. PubMed ID: 19938138
    [Abstract] [Full Text] [Related]

  • 12. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis.
    Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, Jain A, Mantry P, Maliakkal B, Khorana A, Schwartz S.
    Liver Transpl; 2007 Jun 15; 13(6):807-13. PubMed ID: 17539001
    [Abstract] [Full Text] [Related]

  • 13. Factors affecting survival and tumor recurrence in patients transplanted for hepatocellular carcinoma and coexistent hepatitis C virus.
    Briceño J, Ruiz J, Ciria R, Naranjo A, Sánchez-Hidalgo J, Luque A, Rufián S, de la Mata M, López-Cillero P.
    Transplant Proc; 2008 Nov 15; 40(9):2990-3. PubMed ID: 19010170
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of hepatitis C virus infection after liver transplantation.
    Böker KH, Dalley G, Bahr MJ, Maschek H, Tillmann HL, Trautwein C, Oldhaver K, Bode U, Pichlmayr R, Manns MP.
    Hepatology; 1997 Jan 15; 25(1):203-10. PubMed ID: 8985291
    [Abstract] [Full Text] [Related]

  • 15. Liver transplantation for malignant diseases: selection and pattern of recurrence.
    Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I.
    World J Surg; 2002 Feb 15; 26(2):257-63. PubMed ID: 11865357
    [Abstract] [Full Text] [Related]

  • 16. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
    Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I.
    Liver Transpl; 2005 Oct 15; 11(10):1242-51. PubMed ID: 16184539
    [Abstract] [Full Text] [Related]

  • 17. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr 15; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 18. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months.
    Orlando G, Manzia T, Baiocchi L, Sanchez-Fueyo A, Angelico M, Tisone G.
    Transpl Immunol; 2008 Nov 15; 20(1-2):43-7. PubMed ID: 18773958
    [Abstract] [Full Text] [Related]

  • 19. Liver transplantation versus liver resection for the treatment of hepatocellular carcinoma.
    Lee KK, Kim DG, Moon IS, Lee MD, Park JH.
    J Surg Oncol; 2010 Jan 01; 101(1):47-53. PubMed ID: 19798686
    [Abstract] [Full Text] [Related]

  • 20. Hepatocellular carcinoma developed on compensated cirrhosis: resection as a selection tool for liver transplantation.
    Scatton O, Zalinski S, Terris B, Lefevre JH, Casali A, Massault PP, Conti F, Calmus Y, Soubrane O.
    Liver Transpl; 2008 Jun 01; 14(6):779-88. PubMed ID: 18508370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.